Adaptimmune Therapeutics PLC

Ownership Transactions Reported by 22 Insiders

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom

Insiders trading volume in the past year

Adaptimmune Therapeutics PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $25.1M Jul 28, 2025
William C. Bertrand JR Chief Operating Officer $63.5K -$14.6K -18.7% Aug 28, 2025
Garry E. Menzel Director $50.5K Jul 1, 2024
Adrian Rawcliffe Chief Executive Officer, Director $25.7K -$52.4K -67.1% Feb 20, 2025
Cintia Piccina Chief Commercial Officer $10.6K -$7.47K -41.4% Feb 20, 2025
Elliot Norry Chief Medical Officer $4.36K -$16.2K -78.7% Feb 20, 2025
John Lunger Chief Patient Supply Officer $4.36K -$14.6K -77% Feb 20, 2025
Gavin Wood Chief Financial Officer $0 Sep 2, 2025
Ali Behbahani Director $0 Aug 15, 2025
James Noble Director Jul 1, 2022
Lawrence M. Alleva Director Jul 1, 2024
Andrew R. Allen Director Jul 1, 2024
David M. Mott Director Jul 1, 2024
Charles Elliott Sigal Director Jul 3, 2023
Helen Tayton Martin Chief Business & Strgy Officer Jan 15, 2024
John Furey Director Jul 1, 2024
Tal Zvi Zaks Director Jul 1, 2022
Priti Hegde Director Jul 1, 2024
Joanna Brewer Chief Scientific Officer Feb 20, 2025
Christopher James Hill Chief Financial Officer Sep 10, 2025
Barbara Gayle Duncan Director Jul 1, 2022
Kristen Hege Director Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Adaptimmune Therapeutics PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.